Watanabe Todd - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 24, 2025, Watanabe Todd's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Director,Officer (See Remarks), and currently has 740,537 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARQT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Watanabe Todd - Insider Non-Derivative Transactions of ARQT Common Stock

Watanabe Todd - Insider Non-Derivative Transactions at ARQT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 25, 2025	Sell -- (Common Stock)	48945	30.36	740537
Nov 22, 2025	Sell -- (Common Stock)	1055	30	793838
Nov 4, 2025	Sell -- (Common Stock)	69	25.4	794893
Nov 4, 2025	Sell -- (Common Stock)	11478	24.71	794962
Oct 29, 2025	Sell -- (Common Stock)	40000	25.03	806440
Oct 3, 2025	Sell -- (Common Stock)	20739	20.04	846440
Oct 2, 2025	Sell -- (Common Stock)	9261	20.02	867179
Oct 2, 2025	Sell -- (Common Stock)	15000	18.91	876440
Sep 10, 2025	Sell -- (Common Stock)	504	17.52	891440
Sep 9, 2025	Sell -- (Common Stock)	9625	17.54	891944
Aug 5, 2025	Sell -- (Common Stock)	11547	14.33	901569